$179.98

Last traded 2023-09-25 — delisted

NYSE · Healthcare · Medical - Distribution · $36.1B mcap · 169M float · 1.01% daily turnover

Revenue

$321.3B +9.3% ▲

5Y CAGR: +11.1%

Gross Profit

$11.5B +15.8% ▲

5Y CAGR: +17.2%

Operating Income

$2.6B +20.8% ▲

5Y CAGR: +5.3%

Net Income

$1.6B +3.0% ▲

EPS (Diluted)

$7.96 +5.7% ▲

EBITDA

$3.6B +65.5% ▲

5Y CAGR: +8.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$214.0B	$238.6B	$262.2B	$294.0B	$321.3B
YoY Growth	+12.7%	+11.5%	+9.9%	+12.1%	+9.3%
Cost of Revenue	$207.0B	$230.3B	$253.2B	$284.0B	$309.9B
Gross Profit	$6.9B	$8.3B	$9.0B	$9.9B	$11.5B
Gross Margin	3.2%	3.5%	3.4%	3.4%	3.6%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$3.6B	$4.8B	$5.3B	$5.7B	$6.5B
Operating Expenses	$4.1B	$5.5B	$6.6B	$5.7B	$8.8B
Operating Income	$2.4B	$2.4B	$2.3B	$2.2B	$2.6B
Operating Margin	1.1%	1.0%	0.9%	0.7%	0.8%
Interest Expense	$183M	$211M	$229M	$157M	$292M
Income Before Tax	$2.2B	$2.2B	$2.2B	$2.0B	$2.3B
Tax Expense	$677M	$517M	$428M	$485M	$691M
Net Income	$1.5B	$1.7B	$1.7B	$1.5B	$1.6B
Net Margin	0.7%	0.7%	0.7%	0.5%	0.5%
EPS (Diluted)	$7.39	$8.04	$8.53	$7.53	$7.96
EBITDA	$3.4B	$3.5B	$3.4B	$2.2B	$3.6B
Shares Outstanding	208M	211M	205M	200M	195M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$85.8B	$81.5B	$75.5B	$80.7B	$83.7B	$85.9B	$78.4B	$84.8B
Cost of Revenue	$82.9B	$78.9B	$72.4B	$77.8B	$80.8B	$82.9B	$74.8B	$81.1B
Gross Profit	$2.9B	$2.6B	$3.1B	$2.9B	$3.0B	$3.1B	$3.6B	$3.6B
Gross Margin	3.4%	3.1%	4.1%	3.6%	3.5%	3.6%	4.6%	4.3%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.6B	$1.5B	$1.6B	$1.7B	$1.7B	$1.8B	$2.0B	$2.1B
Operating Expenses	$1.6B	$1.5B	$1.6B	$1.7B	$2.9B	$1.8B	$2.4B	$2.5B
Operating Income	$205M	$706M	$1.0B	$868M	$19M	$760M	$1.1B	$1.1B
Operating Margin	0.2%	0.9%	1.4%	1.1%	0.0%	0.9%	1.5%	1.3%
Interest Expense	-$2M	$28M	$104M	$82M	$78M	$72M	$140M	$155M
Income Before Tax	$165M	$620M	$929M	$896M	-$187M	$709M	$2.1B	$996M
Tax Expense	$77M	$127M	$211M	$207M	$146M	$143M	$459M	$220M
Net Income	$77M	$489M	$718M	$687M	-$340M	$560M	$1.6B	$764M
Net Margin	0.1%	0.6%	1.0%	0.9%	-0.4%	0.7%	2.1%	0.9%
EPS (Diluted)	$0.48	$2.50	$3.68	$3.52	$-1.75	$2.87	$8.40	$3.94
EBITDA	-$508M	$706M	$1.0B	$868M	$150M	$135M	$1.4B	$2.0B
Shares Outstanding	200M	195M	195M	195M	194M	195M	195M	194M

ABC NYSE